A close relative of the blueberry, cranberry and huckleberry, the wild bilberry is loaded with potent antioxidants including flavonoids and anthocyanins. Bilberries also have high levels of tannins which are astringent, plant polyphenols. These major components are responsible for bilberries powerful anti-inflammatory and antioxidant activity. Sometimes referred to as the European blueberry, wild bilberries have been used in traditional European medicine for over one thousand years.

The flavonoid compounds found in raw bilberries, called anthocyanins are plant pigments which have amazing anti-aging, anti-oxidant and healing qualities. Anthocyanin can fight free radicals in the body, strengthen blood capillaries and improve overall circulatory health. Bilberries are smaller than blueberries and their pigment is evenly distributed throughout the skin and flesh of the skin, unlike blueberries where the main amount of pigment resides in the skin of the berry. The anthocyanins found in this berry can also reduce the formation of blood clots, a leading cause of heart attack and stroke. Bilberry is useful in fighting numerous vascular and blood disorders such as chilblains, broken veins, varicose veins, thrombosis and angina. It has even been known to reduce damage of blood vessel deterioration and the degradation of blood platelets due to its ability to restore tissue connectivity. Bilberries can strengthen coronary arteries and prevent coronary blockages by fighting the accumulation of ingested fat.

Wild bilberries have long been used as a natural remedy for night vision and to promote overall visual health. British Royal Air Force pilots were known to eat bilberry preserve during World War II to help them see clearly during night missions. Daily use can improve visual acuity and can help a person's eyes to adjust during the dark of night as well as the glare of bright daylight due to the protection of rhodopsin or retinal purple in the eye. The Bilberry may even help a variety of eye disorders including glaucoma, nearsightedness, cataracts and macular degeneration (a disorder that can lead to blindness). Bilberry has been helpful to diabetics who have suffered visual problems due to microcirculation and diabetes mellitus.

Some possible benefits of our raw Bilberry powder may include:

● Alleviating diarrhea
● Helping to protect & enhance vision
● Lowering blood sugar levels
● Reducing inflammation associated with rheumatoid arthritis
● Diuretic effects
● Increasing blood supply to the nervous system
● Improving overall circulatory health
● Improving capillary function
● Fighting urinary tract infections
● Anti-ulcer properties

Bilberries have been used for years to aid a variety of illnesses and to improve overall circulatory health and to promote healthy vision. With amazing healing qualities, antioxidant properties and the powerful anthocyanins, you may see that our wild Bilberry powder is right for you!

Suggested Use: Mix 1 - 2 teaspoons with juice, yogurt or add to your favorite smoothie.

Botanical Name: Vaccinium Myrtillus

Other Names: Whortleberries, European blueberry, bog berry, hurtleberry

Origin: Albania - Certified Organic

Z Natural Foods strives to offer the highest quality organically grown, raw, vegan, gluten free, non-GMO products available and exclusively uses low temperature drying techniques to preserve all the vital enzymes and nutrients. Our Raw Bilberry Powder is certified organic and passes our strict quality assurance which includes testing for botanical identity, heavy metals, chemicals and microbiological contaminants. ZNaturalFoods.com offers Organic Raw Bilberry Powder packaged in airtight stand-up, resealable foil pouches for optimum freshness. Once opened, just push the air out of the pouch before resealing it in order to preserve maximum potency. Keep your Raw Organic Bilberry Fruit Powder in a cool, dark, dry place.

References:

1. Anderhuber, R. 1991. Vaccinium myrtillus . Aust J Med Herbalism 3:13–14

2. Azar, M., E. Verette, S. Brun. 1987. Identification of some phenolic compounds in bilberry juice Vaccinium myrtillus. J Food Sci 52(5):1255–1257

3. Barrette, E.P. 1999. Bilberry fruit extract for night vision. Alternative Medicine Alert™ 2(2):20–21

4. Bone, K. and M. Morgan. 1997. Bilberry—The Vision Herb. MediHerb Professional Review 59:1–4

5. Braun, R. et al. 1997. Standardzulassungen für Fertigarzneimittel—Text and Kommentar. Stuttgart: Deutscher Apotheker Verlag

6. Bravetti, G. 1989. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: clinical evaluation. Ann Ottalmol Clin Ocul 115:109

7. Bruneton, J. 1995. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing

8. Bundesanzeiger (BAnz). 1998. Monographien der Kommission E (Zulassungs- und Aufbereitungskommission am BGA für den humanmed. Bereich, phytotherapeutische Therapierichtung und Stoffgruppe). Köln: Bundesgesundheitsamt (BGA)

9. Caselli, L. 1985. Studio clinico ed elettroretinografico sull'attivita degli antocianosidi [Clinical and electroretinographic study on activity of anthocyanosides]. Arch Med Int (Parma) 37:29–35

10. Cluzel, C., P. Bastide, P. Tronche. 1969. [Phosphoglucomutase and glucose-6-phosphatase activities of the retina and anthocyanoside extracts from Vaccinium myrtillus (study in vitro and in vivo )] [In French]. C R Seances Soc Biol Fil 163(1):147–150

11. Colantuoni, A., S. Bertuglia, M.J. Magistretti, L. Donato. 1991. Effects of Vaccinium myrtillus anthocyanosides on arterial vasomation. Arzneimforsch 41(9):905–909.

12. Cunio, L. 1993. Vaccinium myrtillus . Aust J Med Herbalism 5(4):81–85

13. Deutscher Arzneimittel-Codex (DAC). 1986. Stuttgart: Deutscher Apotheker Verlag

14. Ferretti, C., M.J. Magistretti, A. Robotti, P. Ghi, E. Genazzani. 1988. Vaccinium myrtillus anthocyanosides are inhibitors of cAMP and cGMP phosphodiesterases. Pharm Res Comm 20(11):150

15. Fiorini, G., A. Biancacci, F.M. Graziano. 1965. Modificazioni perimetriche ed adattometriche dopo ingestione di mirtillina associata a beta-carotene [Perimetric and adaptometric modifications after ingestion of myrtillin associated with beta-carotene]. Ann Ottalmol Clin Ocul 91(6):371–386

16. Foster, S. 1996. Bilberry: A Long History. Health Food Business. August 1996: 40

17. Friedrich, V.H. and J. Schönert. 1973. Untersuchungen über einige Inhaltsstoffe der Blätter und Früchte von Vaccinium myrtillus [Phytochemical investigation of leaves and fruits of Vaccinium myrtillus ]. Planta Med 24(1):90–100

18. German Homeopathic Pharmacopoeia (GHP). 1993. Translation of the Deutsches Homöopathisches Arzneibuch (HAB 1), 1st ed., 5th suppl. 1991. Stuttgart: Deutscher Apotheker Verlag. 383–384

19. Ghiringhelli, C., F. Gregoratti, F. Marastoni. 1978. Attivita capillarotrop di antocianosidi and alto dosaggio nella stasi da flebopatia [Capillarotropic activity of anthocyanosides in high doses in phlebopathic statis]. Minerva Cardioangiol 26(4):255–276

20. Grieve, M. 1979. A Modern Herbal. New York: Dover Publications, Inc.

21. Hänsel, R., K. Keller, H. Rimpler, G. Schneider (eds.). 1992–1994. Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Vol. 4–6. Berlin-Heidelberg: Springer Verlag

22. Jayle, G.E. and L. Aubert. 1964. [Action des glucosides d'anthocyanes sur la vision scotopique et mesopique du sujet normal] [In French]. Therapie 19:171

23. Jayle, G.E. et al. 1965. [Study concerning the action of anthocyanoside extracts of Vaccinium Myrtillus on night vision] [In French]. Ann Ocul (Paris) 198(6):556–562

24. Lagrue, G. et al. 1979. Pathology of the microcirculation in diabetes and alterations of the biosynthesis of intracellular matrix molecules. Front Matrix Biol S Karger 7:324–325

25. Leung, A.Y. and S. Foster. 1996. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 2nd ed. New York: John Wiley & Sons, Inc. 84–85

26. Lietti, A., A. Cristoni, M. Picci. 1976. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimforsch 26(5):829–832

27. Meyer-Buchtela, E. 1999. Tee-Rezepturen—Ein Handbuch für Apotheker und Ärzte. Stuttgart: Deutscher Apotheker Verlag

28. Morazzoni, P. and E. Bombardelli. 1996. Vaccinium myrtillus L. Fitoterapia 67(1):3–29

29. Neumann, L. 1971. Therapeutische Versuche mit Anthozyanosiden bei Langzeitbehandlungen in der Augenheilkunde [In German]. Klin Monatsbl Augenheilkd 158:592–597

30. Österreichisches Arzneibuch, 1st suppl. (ÖAB). 1983. Wien: Verlag der Österreichischen Staatsdruckerei

31. Österreichisches Arzneibuch (ÖAB). 1991. Wien: Verlag der Österreichischen Staatsdruckerei

32. Pennarola, R. et al. 1980. The therapeutic action of the anthocyanosides in microcirculatory changes due to adhesive-induced polyneuritis. Gazz Med Ital 139:485–491

33. Perossini, M. et al. 1987. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens): Double blind placebo controlled clinical trial. Ann Ottalmol Clin Ocul 113:1173

34. Pharmacopoeia Helvetica, 7th ed. Vol. 1–4. (Ph.Helv.VII). 1987. Bern: Office Central Fédéral des Imprimés et du Matériel

35. Pizzorno, J.E. and M.T. Murray. 1992. A Textbook of Natural Medicine. Seattle, WA: Bastyr University Publications

36. Politzer, M. 1977. [Experiences in the medical treatment of progressive myopia] [In German]. Klin Monatsbl Augenheilkd 171(4):616–619

37. Regtop, H. 1998. Age related macular degeneration. Aust J Med Herbalism 10(2):38–45

38. Scharrer, A. and M. Ober. 1981. Anthocyanoside in der Behandlung von Retinopathien [Anthocyanosides in the treatment of retinopathies] [In German]. Klin Monatsbl Augenheilkd 178(5):368–389

39. Sevin, R. and J.F. Cuendet. 1966. Effets d'une association d'anthocyanosides de myrtille et de beta-carotene sur la resistance capillaire des diabetiques [In French]. Ophthalmologica 152:109–117

40. Tyler, V.E. 1994. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: Pharmaceutical Products Press

41. Wichtl, M. and N.G. Bisset (eds.). 1994. Herbal Drugs and Phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers. 351–352

42. Wichtl, M. 1996. Monographien—Kommentar. In: Braun, R. et al. 1997. Standardzulassungen für Fertigarzneimittel—Text and Kommentar. Stuttgart: Deutscher Apotheker Verlag

43. Zavarise, G. 1968. Sull'effetto del trattamento prolungato con antocianosidi sul senso luminoso [Effect of prolonged treatment with anthocyanosides on light senstivity]. Ann Ottalmol Clin Ocul 94(2):209–214.